Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NIAID initiates trial evaluating AEOL-10150 for treating radiation exposure

June 8, 2009

Cleveland BioLabs concludes initial phase I safety study for CBLB-502

June 4, 2009

Catalyst reports results for phase II CPP-109 trial for cocaine addiction

June 2, 2009

Alkermes commences new ALKS-33 trials

May 14, 2009

Alkermes presents update on the clinical development of Vivitrol

April 22, 2009

Melanin-concentrating hormone system may play role in addiction

April 22, 2009

EVT-302 shows no benefit as aid to smoking cessation

April 15, 2009

ImmuneRegen and University of Rochester to examine Homspera in lethal radiation exposure

April 15, 2009

Catalyst halts enrollment into phase II trial of CPP-109 for methamphetamine addiction

March 6, 2009

Camurus initiates phase I/II CAM-2038 trial for opiate addiction

Feb. 25, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...